Home > Healthcare > Healthcare IT > Telehealth > Tele-epilepsy Market

Tele-epilepsy Market Share

Report ID: GMI11022
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Tele-epilepsy Market Share

The market is characterized by several key players focusing on technological innovations and service expansion. Companies are increasingly investing in advanced telehealth platforms, remote monitoring solutions, and AI-driven diagnostic tools to enhance patient care and differentiate their offerings. Strategic partnerships, collaborations with healthcare providers, and integration with electronic health records (EHR) systems are common strategies for increasing market share. Additionally, companies are emphasizing patient-centric approaches by offering personalized treatment plans and improving accessibility to specialized care, which collectively drive competition and innovation in the market.

Tele-epilepsy Market Companies

Few of the prominent players operating in the tele-epilepsy industry include:

Bioserenity SAS
Ceribell, Inc.
CortiCare, Inc.
Epitel, Inc.
Empatica Inc.
MedaSync
Medtronic plc
NeuroPace, Inc.
Ovation Healthcare
Real Time Tele-Epilepsy Consultants.
ScienceSoft USA Corporation
Seer Medical.
Teladoc Health, Inc.
UCB S.A.
Vidyo, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The tele-epilepsy industry size was valued at USD 408.1 million in 2023 and will witness 15.9% CAGR from 2024 to 2032 driven by the increasing prevalence of epilepsy and the rising demand for remote management solutions.

The software component segment in the market is anticipated to grow at 16.2% CAGR through 2032 attributed to its vital role in facilitating remote monitoring and epilepsy management, providing stakeholders with essential tools for data collection and patient engagement.

U.S. tele-epilepsy industry size is anticipated to reach USD 795.5 million by 2032 fueled by the high prevalence of epilepsy, which creates substantial demand for advanced management solutions.

Bioserenity SAS, Ceribell, Inc., CortiCare, Inc., Epitel, Inc., Empatica Inc., MedaSync , Medtronic plc, NeuroPace, Inc., and Ovation Healthcare